Omni Bio Pharmaceutical, Inc. (OTCBB:OMBP) announced that it will receive up to $1,000,000 in a round of funding on March 16, 2015. The company will issue non-convertible debt and option, warrant or other right to acquire another security in the transaction. The minimum investment accepted from any outside investor is $50,000.

The company will issue securities pursuant to exemption provided under Regulation D.